Maravai LifeScience Holdings Inc. (MRVI) PT Raised to $56 at Stifel
Tweet
Share
E-mailGet Alerts MRVI Hot Sheet
Price: $8.29 +14.82%
Rating Summary:
7 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
7 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Stifel analyst Daniel Arias raised the price target on Maravai LifeScience Holdings Inc. (NASDAQ: MRVI) to $56.00 (from $50.00) while maintaining a Buy rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- LB Pharmaceuticals Inc (LBRX) PT Raised to $69 at Clear Street
- Myriad Genetics (MYGN) PT Lowered to $2.50 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
